Literature DB >> 30508570

17B-hydroxysteroid dehydrogenases as acyl thioester metabolizing enzymes.

J Kalervo Hiltunen1, Alexander J Kastaniotis2, Kaija J Autio3, Guangyu Jiang3, Zhijun Chen4, Tuomo Glumoff3.   

Abstract

17β-Hydroxysteroid dehydrogenases (HSD17B) catalyze the oxidation/reduction of 17β-hydroxy/keto group in position C17 in C18- and C19 steroids. Most HSD17Bs are also catalytically active with substrates other than steroids. A subset of these enzymes is able to process thioesters of carboxylic acids. This group of enzymes includes HSD17B4, HSD17B8, HSD17B10 and HSD17B12, which execute reactions in intermediary metabolism, participating in peroxisomal β-oxidation of fatty acids, mitochondrial oxidation of 3R-hydroxyacyl-groups, breakdown of isoleucine and fatty acid chain elongation in endoplasmic reticulum. Divergent substrate acceptance capabilities exemplify acquirement of catalytic site adaptiveness during evolution. As an additional common feature these HSD17Bs are multifunctional enzymes that arose either via gene fusions (HSD17B4) or are incorporated as subunits into multifunctional protein complexes (HSD17B8 and HSD17B10). Crystal structures of HSD17B4, HSD17B8 and HSD17B10 give insight into their structure-function relationships. Thus far, deficiencies of HSD17B4 and HSD17B10 have been assigned to inborn errors in humans, underlining their significance as enzymes of metabolism.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  17β-Hydroxysteroids; Fatty acid synthesis; Fatty acyl thioesters; Lipid metabolism; Multifunctional proteins; RNase P; β-Oxidation

Mesh:

Substances:

Year:  2018        PMID: 30508570     DOI: 10.1016/j.mce.2018.11.012

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  9 in total

1.  PRSS37 deficiency leads to impaired energy metabolism in testis and sperm revealed by DIA-based quantitative proteomic analysis.

Authors:  Wenfeng Xiong; Haoyang Ge; Chunling Shen; Chaojie Li; Xiaohong Zhang; Lingyun Tang; Yan Shen; Shunyuan Lu; Hongxin Zhang; Zhugang Wang
Journal:  Reprod Sci       Date:  2022-04-26       Impact factor: 3.060

2.  HSD17B13 and other liver fat-modulating genes predict development of hepatocellular carcinoma among HCV-positive cirrhotics with and without viral clearance after DAA treatment.

Authors:  Michela E Burlone; Mattia Bellan; Matteo N Barbaglia; Ginevra Mocchetti; Venkata R Mallela; Rosalba Minisini; Cristina Rigamonti; Mario Pirisi
Journal:  Clin J Gastroenterol       Date:  2022-01-31

3.  Coding Variants in Susceptibility to Diabetic Kidney Disease.

Authors:  Lili Liu; Krzysztof Kiryluk
Journal:  J Am Soc Nephrol       Date:  2021-10       Impact factor: 14.978

4.  Down-Regulating the High Level of 17-Beta-Hydroxysteroid Dehydrogenase 13 Plays a Therapeutic Role for Non-Alcoholic Fatty Liver Disease.

Authors:  Meixi Wang; Jianrui Li; Hu Li; Biao Dong; Jing Jiang; Nannan Liu; Jiali Tan; Xuekai Wang; Lei Lei; Hongying Li; Han Sun; Mei Tang; Huiqiang Wang; Haiyan Yan; Yuhuan Li; Jiandong Jiang; Zonggen Peng
Journal:  Int J Mol Sci       Date:  2022-05-16       Impact factor: 6.208

5.  Diabetes risk loci-associated pathways are shared across metabolic tissues.

Authors:  Gerard A Bouland; Joline W J Beulens; Joey Nap; Arno R van der Slik; Arnaud Zaldumbide; Leen M 't Hart; Roderick C Slieker
Journal:  BMC Genomics       Date:  2022-05-14       Impact factor: 4.547

6.  Identification, Expression and Evolution of Short-Chain Dehydrogenases/Reductases in Nile Tilapia (Oreochromis niloticus).

Authors:  Shuai Zhang; Lang Xie; Shuqing Zheng; Baoyue Lu; Wenjing Tao; Xiaoshuang Wang; Thomas D Kocher; Linyan Zhou; Deshou Wang
Journal:  Int J Mol Sci       Date:  2021-04-18       Impact factor: 5.923

7.  3-Hydroxyacyl-CoA and Alcohol Dehydrogenase Activities of Mitochondrial Type 10 17β-Hydroxysteroid Dehydrogenase in Neurodegeneration Study.

Authors:  Xue-Ying He; Carl Dobkin; W Ted Brown; Song-Yu Yang
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

8.  Association of Coding Variants in Hydroxysteroid 17-beta Dehydrogenase 14 (HSD17B14) with Reduced Progression to End Stage Kidney Disease in Type 1 Diabetes.

Authors:  Josyf C Mychaleckyj; Erkka Valo; Takaharu Ichimura; Tarunveer S Ahluwalia; Christian Dina; Rachel G Miller; Ivan G Shabalin; Beata Gyorgy; JingJing Cao; Suna Onengut-Gumuscu; Eiichiro Satake; Adam M Smiles; Jani K Haukka; David-Alexandre Tregouet; Tina Costacou; Kristina O'Neil; Andrew D Paterson; Carol Forsblom; Hillary A Keenan; Marcus G Pezzolesi; Marlon Pragnell; Andrzej Galecki; Stephen S Rich; Niina Sandholm; Ronald Klein; Barbara E Klein; Katalin Susztak; Trevor J Orchard; Ron Korstanje; George L King; Samy Hadjadj; Peter Rossing; Joseph V Bonventre; Per-Henrik Groop; James H Warram; Andrzej S Krolewski
Journal:  J Am Soc Nephrol       Date:  2021-07-14       Impact factor: 14.978

Review 9.  Is HSD17B13 Genetic Variant a Protector for Liver Dysfunction? Future Perspective as a Potential Therapeutic Target.

Authors:  Takashi Motomura; Sriram Amirneni; Ricardo Diaz-Aragon; Lanuza A P Faccioli; Michelle R Malizio; Michael C Coard; Zehra N Kocas-Kilicarslan; Carla Frau; Nils Haep; Alina Ostrowska; Rodrigo M Florentino; Alejandro Soto-Gutierrez
Journal:  J Pers Med       Date:  2021-06-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.